1. The association of preconceptional folic acid supplementation with gestational age and preterm birth risk in twin pregnancies: a prospective cohort study in China.
- Author
-
Xia, Yuanqing, Huang, Lili, Long, Zichong, Chen, Yiting, Gao, Li, Hua, Renyi, Li, Shenghui, and Wang, Yanlin
- Subjects
THERAPEUTIC use of folic acid ,VITAMINS ,PREMATURE infants ,CONFIDENCE intervals ,GESTATIONAL age ,PREGNANT women ,REGRESSION analysis ,DIETARY supplements ,PREGNANCY outcomes ,PREGNANCY complications ,HUMAN reproductive technology ,DRUGS ,RESEARCH funding ,DELIVERY (Obstetrics) ,LOGISTIC regression analysis ,ODDS ratio ,PATIENT compliance ,PRECONCEPTION care ,MULTIPLE pregnancy ,LONGITUDINAL method ,PREGNANCY - Abstract
Purpose: This study aims to explore the association of maternal preconceptional folic acid (FA) supplementation with gestational age and preterm birth in twin pregnancies, and whether the association varies by chorionicity or conception mode. Methods: From November 2018 to December 2021, the information of FA supplementation and pregnancy outcomes were collected in twin pregnant women. The linear regression models and the logistic regression were used to test the association of preconceptional FA supplementation with gestational age at delivery and preterm birth and premature rupture of membranes (PROM). Results: A total of 416 twin pregnancies were included. Compared with no use in twins, maternal preconceptional FA use was associated with a 0.385-week longer gestational age (95% CI 0.019–0.751) and lower risk of preterm birth < 36 weeks (adjusted OR 0.519; 95% CI 0.301–0.895) and PROM (adjusted OR 0.426; 95% CI 0.215–0.845). The protective effect on preterm birth < 36 weeks and PROM is similar whether taking FA supplements alone or multivitamins. However, the associations varied by chorionicity and conception mode of twins or compliance with supplementation. The positive associations between preconceptional FA use and gestational age only remained significant among twins via assisted reproductive technology or dichorionic diamniotic twins. Significant protective effects on preterm birth < 36 weeks and PROM were only found among women who took FA at least 4 times a week before conception. Conclusion: Maternal preconceptional FA supplementation was associated with longer gestation duration and lower risk of preterm birth < 36 weeks and PROM in twin pregnancies. To improve the success of their pregnancies, reproductive women should start taking FA supplements well before conception and with good compliance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF